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Focal adhesion kinase (FAK) is a non-receptor tyrosine kinase
that localizes to focal adhesions in adherent cells. Through phos-
phorylation of proteins assembled at the cytoplasmic tails of inte-
grins, FAK promotes signaling events that modulate cellular
growth, survival, andmigration. The amino-terminal region of FAK
contains a region of sequence homology with band 4.1 and ezrin/
radixin/moesin (ERM) proteins termed a FERM domain. FERM
domains are found in a variety of signaling and cytoskeletal proteins
and are thought to mediate intermolecular interactions with part-
ner proteins and phospholipids at the plasma membrane and
intramolecular regulatory interactions. Here we report two crystal
structures of an NH2-terminal fragment of avian FAK containing
the FERM domain and a portion of the regulatory linker that con-
nects the FERM and kinase domains. The tertiary folds of the three
subdomains (F1, F2, and F3) are similar to those of known FERM
structures despite low sequence conservation. Differences in the
sequence and relative orientation of the F3 subdomain alters the
nature of the interdomain interface, and thephosphoinositide bind-
ing site found in ERM family FERM domains is not present in FAK.
A putative protein interaction site on the F3 lobe is masked by the
proximal region of the linker. Additionally, in one structure the
adjacent Src SH3 and SH2 binding sites in the linker associate with
the surfaces of the F3 and F1 lobes, respectively. These structural
features suggest the possibility that protein interactions of the FAK
FERM domain can be regulated by binding of Src kinases to the
linker segment.
The adhesion of cells to the extracellular matrix is mediated by the
integrin family of cell surface receptors (1). Extracellularmatrix engage-
ment triggers conformational changes and clustering of integrins lead-
ing to the remodeling of protein complexes at focal adhesions (2). These
intracellular complexes contain actin-cytoskeletal proteins and signal-
ing molecules that regulate a number of processes including cell migra-
tion, proliferation, and differentiation (3). Focal adhesion kinase (FAK)3
is present at focal adhesions and becomes both tyrosine-phosphorylated
and activated in response to integrin signaling (4–6). As a potential
mediator of integrin signaling, it is important to understand how FAK is
activated and regulated.
FAK and the related tyrosine kinase Pyk2 (also referred to as CAK-,
RAFTK, or CADTK) comprise a subfamily of non-receptor protein-
tyrosine kinases defined by a central tyrosine kinase domain flanked by
an amino-terminal FERMdomain and a carboxyl-terminal domain. The
latter domain contains a proline-rich region that interacts with other
signaling molecules and a distal focal adhesion targeting domain (Fig.
1A). Autophosphorylation of FAK at Tyr397 within a linker region
between the FERM and kinase domain creates a binding site for SH2-
containing proteins such as Src family kinases, the p85 subunit of phos-
phatidylinositol 3-kinase, and Grb7 (7–11). An adjacent RXXPXXP
motif serves as a binding site for the Src family SH3 domain and con-
tributes to the efficient recruitment of Src family kinases to FAK (12,
13). Subsequent phosphorylation of tyrosines (Tyr576 andTyr577) within
the kinase domain of FAK by the associated Src family kinase leads to
the formation of an active signaling complex (14). Through phospho-
rylation of additional proteins assembled at the cytoplasmic tails of inte-
grins, FAK and Src promote signaling events that modulate cellular
growth, survival, and migration (6, 15, 16).
The amino terminus of FAK and Pyk2 share a region of homology
with membrane-cytoskeletal linker proteins ezrin, radixin, and moesin
(referred to collectively as ERM proteins) (17). The band 4.1 and ERM
homology domain (FERM domain) is a module of 300 amino acids
found in a number of proteins that are membrane targeted (18). FERM
domains of ERM proteins interact directly with the cytoplasmic regions
of transmembrane receptors (19–21). In addition, association of the
FERM domain with the phosphoinositide phosphatidylinositol 4,5-P2
has been demonstrated both structurally and with vesicle co-sedimen-
tation (22–24). Mutagenesis of the basic residues within the FERM
domain thatmediate the phosphoinositide interaction alters the subcel-
lular distribution of the protein (24, 25). These findings suggest that
both protein-protein and protein-lipid interactions may be responsible
for the efficient localization of FERM-containing proteins tomembrane
targets.
In addition to a general role as a membrane localization module, the
FERM domain may serve additional regulatory functions. Among the
518 protein kinases annotated within the human genome, FERM
domains are not a common accessory domain and are only foundwithin
FAK and Janus kinase families (26). The association of Janus kinases
with the cytoplasmic tails of cytokine receptors is dependent on the
FERM domain (27–30). Mutations in the Janus kinase 3 FERM domain
inhibit receptor binding and may abrogate kinase activity (31).
To date, several interactions involving the FERM domain of FAK
have been described including those with the cytoplasmic tails of inte-
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grins, the pleckstrin homology domain of the Tec-family kinase Etk, and
the FERM domain of ezrin (32–35). Association with activated growth
factor receptors and the promotion of cell migration in response to
growth factor signaling is dependent on an intact FERMdomain of FAK
(36). Immunolocalization experiments have suggested that the FERM
domain of FAK is sufficient for localization to membrane substructures
such as at the leading edge of lamellipodia and cell-cell junctions, and
although not directly responsible for focal adhesion targeting, canmod-
ulate the localization of the protein (37, 38). Finally, a direct interaction
between the FERMand kinase domains of FAKmay regulate the activity
of the kinase (39–42). Interestingly, sequences in the F2 subdomain of
the FAK FERM domain play a role in activation of FAK signaling fol-
lowing cell adhesion (40). The physical nature of these interactions
remains to be elucidated.
To better understand the function of the FERM domain of FAK, and
as a starting point for dissecting its inter- and intramolecular interac-
tions, we have determined its structure in two crystal forms at resolu-
tions of 2.5 Å and 2.35 Å. The tri-lobed architecture of ERM family
FERM domains is preserved in FAK (22, 43–47), but a unique orienta-
tion of the F3 subdomain alters the global conformation of the domain
as compared with all previously studied FERM domains. The structures
show that the phosphatidylinositol 4,5-P2 binding site found in ERM
family FERM domains is not preserved in FAK. Additionally, the struc-
tures reveal that the FERM-kinase linker segment masks a potential
protein interaction site on the F3 lobe; the corresponding site in the talin
and radixin FERM domains has been shown to bind the cytoplasmic
tails of  integrins and ICAM-2, respectively (21, 48). We hypothesize
that this masking interaction could be released by binding of Src family
proteins to their adjacent docking sites in the linker.
EXPERIMENTAL PROCEDURES
Materials—Restriction andmodifying enzymeswere purchased from
New England Biolabs. Oligonucleotides were from Sigma; B834
Escherichia coli cells were from Novagen. Seleno-L-methionine was
from Sigma; metal chelating, ion exchange, and gel filtration columns
were from Amersham Biosciences.
Protein Expression and Purification—The FERM domain of avian
FAK was amplified by PCR from cDNA (Swiss-Prot accession number
Q00944). DNA fragments encoding amino acids 1–405, 31–405, and
31–399 were each ligated into a modified pET vector containing an
amino-terminal His6 tag with a tobacco etch virus cleavage site and
confirmed by DNA sequencing. The expression of recombinant protein
in E. coli BL21(DE3) cells was induced at an optical density (A600) of 0.8
by the addition of 0.2 mM isopropyl -D-thiogalactopyranoside and
grown for an additional 12–16 h at 18 °C. The cells were harvested and
the pellets were stored frozen at 70 °C. Cell pellets were thawed in
buffer A (20 mM Tris, pH 8.0, 200 mM NaCl, 5 mM imidazole, 5 mM
-mercaptoethanol) with the addition of 1 mM phenylmethylsulfonyl
fluoride, 10 g/ml leupeptin, 1 mM benzamadine, 10 mg/ml lysozyme,
and 1 mg/ml DNase. Cell membranes were disrupted by sonication on
ice and supernatants obtained following a 30-min centrifugation at
50,000  gwere loaded onto a Ni-chelating column. Protein was eluted
with buffer A containing 200 mM imidazole. FERM domain-containing
fractions were pooled and the His6 tag was cleaved by incubation with 1
g of tobacco etch virus protease per mg of protein overnight at 4 °C.
The concentration of NaCl was reduced to 50 mM by dilution, and the
protein was loaded onto a HiTrap Q column and eluted with buffer A
containing 500 mM NaCl. The FERM domain was concentrated and
loaded onto a Superdex 75 size exclusion column previously equili-
brated in buffer A containing 100 mM NaCl. The eluted FERM domain
of FAK was greater than 95% pure as estimated by SDS-PAGE and was
concentrated to 6–10 mg/ml and stored at 70 °C.
Selenomethionine (SeMet)-substituted protein was prepared using
the methionine auxotroph B834(DE3) strain. Cells were grown in M9
minimal media supplemented with SeMet (40 g/ml). The subsequent
steps for SeMet-labeled FERM domain proceeded as described for the
native protein.
Crystallization andData Collection—Protein crystals of FAK399 (res-
idues 31–399 of avian FAK) were obtained by the hanging dropmethod
using 6–10 mg/ml protein mixed in a 1:1 volume ratio with precipita-
tion solution containing 100 mM Tris, pH 8.0, 16–22% polyethylene
glycol 4000, 20% glycerol, 200 mM NaCl, 100 mM CsCl, 10 mM dithio-
threitol. Crystals grew over 1–2 weeks at room temperature reaching
maximum dimensions of 40  100  20 m. Diffraction data were
recorded to 2.5-Å resolution from a single, frozen native crystal with a
monoclinic space group, P21 and unit cell parameters a  44.2, b 
146.2, c  68.9Å,   96.4°. Multiple anomalous diffraction data on a
single, frozen, SeMet-derivatized FAK399 crystal was collected at the
NSLS X12C beamline to 2.9-Å resolution (see Table 1 for details). Crys-
tals of FAK405 (residues 31–405) were grown in 22.5% polyethylene
glycol 4000, 0.1M citrate, pH5.5, 0.2M ammoniumacetate, 20% glycerol,
and in the presence of 1:2 molar ratio of inositol (1,4,5)P3. The phos-
phoinositide head group did not affect crystallization and is not present
in the crystal structure. Diffraction data from a single frozen crystal with
an orthorhombic space group (unit cell a  50.54, b  123.99, c 
133.93 Å) was collected at APS (14-ID-B) to 2.35-Å maximum
resolution.
Structure Determination—The program SOLVE was used to deter-
mine the position of 10 selenium atoms from two copies of the FERM
domain in the asymmetric unit in the FAK399 structure. The initial
electron density map was improved by solvent flattening and phase-
extension to 2.5-Å resolution using program DM (49). A partial model
was built automatically using the program ARP/wARP (50). The struc-
ture was completed and refined with several rounds of manual rebuild-
ing using the program O and atomic refinement with CNS. The model
was assessed using PROCHECK (51) and waters were added by CNS.
The refined model contains residues 33–363 of FAK, whereas residues
31–32 and 364–399 were not visible in the electron density maps and
presumed to be disordered.
The structure of FAK405 was phased by molecular replacement using
the previously determined FAK399 FERM structure as the search model
and the program Phaser (52). Difference electron density maps revealed
that the ordered portion of one of the two molecules in the asymmetric
unit extended to residue 375, and also revealed density corresponding to
residues 394–403 and 394–401 in the linker regions of the two mole-
cules. These regions were built and the FAK405 structure was refined as
described above for the FAK399 structure.
RESULTS
Domain Mapping, Crystallization, and Structure Determination—
The amino-terminal fragment of FAK (residues 1–405) containing the
predicted FERM domain and autophosphorylation site Tyr397 was
expressed in E. coli and purified. Limited proteolysis with the protease
trypsin and amino-terminal sequencing of the resulting polypeptide
identified a cleavage event that removed the NH2-terminal 28 residues
of FAK (data not shown). Analysis of the FERMregion of FAKandPYK2
from a number of species revealed that sequence conservation initiated
with Arg35 (numbering refers to avian FAK). A truncated protein con-
taining residues 31–399 (referred to here as FAK399) was generated and
producedmonoclinic crystals that diffracted x-rays to better than 2.5-Å
FAK FERM Domain Structure
JANUARY 6, 2006 • VOLUME 281 • NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 253
resolution. The FAK399 structure was determined by multiwavelength
anomalous diffraction methods using SeMet-substituted protein. We
also obtained crystals with a longer construct spanning residues 31–405
(FAK405); this structure was determined by molecular replacement
using the FAK399 structure as amodel. The two structures are essentially
the same; the only notable exception is that in the FAK405 structure, we
observe electron density for a portion of the FERM-kinase linker corre-
sponding to the Src SH3 binding site (residues 364 to 375) and for the
segment containing the Tyr397 autophosphorylation site (residues 394–
403). These segments are not ordered or completely present in the
FAK399 crystals. Our description of the structure below is based upon
the FAK399 crystals, but we refer explicitly to FAK399 or FAK405 as nec-
essary for correctness and clarity.
The FAK399 protein crystallized in monoclinic space group P21 with
two molecules in the asymmetric unit. The final model contains two
molecules of the FERM domain and 243 water molecules and has been
refined to an R value of 19.6% (Rfree  24.9%) at 2.5-Å resolution with
excellent stereochemistry (Table 1). The first 2 residues (Gly31-Ala32)
and the COOH-terminal 37 residues (Lys364-Glu399) in each molecule
are not visible in the electron density; this disordered region includes
the Src SH3 binding site (Arg368-Pro374) and theTyr397 phosphorylation
site. FAK405 protein crystallized in the orthorhombic space group
P212121, also with two molecules in the asymmetric unit. Residues
Ser307-Arg312, Leu376-Glu393, and Glu404-Asp405 were not observed in
the electron density and are not included in the finalmodel. The FAK405
structure has been refined to an R value of 21.0% (Rfree  25.2%) with
good stereochemistry (Table 1 and “Experimental Procedures”).
Structure of the FAK FERMDomain—The FAK structure reveals the
three-lobed architecture characteristic of the archetypal FERM
domains of ERM family members ezrin (47), radixin (22), and moesin
(43) (Fig. 1B). The three subdomains (labeled F1, F2, and F3) intimately
associate with one another to form a compact structure with the overall
shape of a cloverleaf. Each of the three lobes of the FERM domain bears
striking similarity to otherwise unrelated single-domain protein struc-
tures as previously noted (43). The F1 lobe spans residues 33–127 and
exhibits a ubiquitin-like fold (53) consisting of a five-stranded -sheet
capped by an -helix. The F2 subdomain (residues 128–253) is all
-helical and contains a core 4-helix bundle similar to that found in the
acyl-CoA-binding protein (54). The F3 lobe (residues 254–352) is a
-sandwich capped by a COOH-terminal -helix that very closely
resembles a pleckstrin homology domain. The pleckstrin homology
domain shares the same three-dimensional fold with other modular
signaling domains including phosphotyrosine binding and EVH1
domains in addition to the F3 lobe of the FERM domain (55). It has
evolved distinct binding sites for diverse protein and phospholipid
ligands (56). Both phosphotyrosine binding domains and the F3 lobe of
some FERM domains bind peptide ligands in a groove formed between
one edge of the -sandwich and the COOH-terminal -helix. Interest-
ingly, this groove is occupied in the FAK FERM domain by residues just
COOH-terminal to the FERM domain in the FERM-kinase linker seg-
ment (Fig. 4). This interaction is observed in both FAK399 and FAK405
and is discussed more fully in a following section.
The two protein molecules in the asymmetric unit are quite similar.
They superimpose with a root mean square (r.m.s.) deviation of 0.9 Å
over 330 amino acids. The only significant structural deviations in the
twomolecules are found in loop regions (the loop connecting2 and3
in the F2 lobe, the loop between strands 3 and 4, and the loop
between strands 5 and 6 loop in the F3 lobe). Similarly, the FAK405
structure superimposes well with that of FAK399 (r.m.s. deviation of 1.2
Å for 324 equivalent residues). Both structures reveal a similar non-
crystallographic dimer interface, but the contact between the two mol-
ecules is small (it buries400 Å2 of surface area on eachmonomer) and
is therefore not suggestive of a biologically relevant dimer. Also, the
isolated FERM domain elutes in size-exclusion chromatography at a
volume consistent with a monomeric protein (data not shown). How-
ever, FAK self-association is thought to play a role in its catalytic regu-
lation and we cannot exclude the possibility that the FERM-FERM
interaction observed in the crystal lattice is part of a larger interaction in
the intact kinase.
Comparison with the Radixin FERM—The FAK FERM domain is
rather distantly related to other FERM domains. For example, it shares
only 12–15% sequence identity with ERM family members (Fig. 1C).
TABLE 1
Data collection and refinement statistics for FAK FERM domain
31–399 SeMet (multiple anomalous diffraction)
31–399 Inflection Peak Remote 31–405
Data collection
Wavelength (Å) 0.97897 0.9796 0.9793 0.95004 1.12714
Resolution (Å) (outer shell)a 30–2.5 (2.57–2.50) 30–2.8 (2.9–2.8) 30–2.8 (2.9–2.8) 30–2.9 (3.0–2.9) 30–2.35 (2.45–2.35)
Space group P21 P21 P21 P21 P212121
Total reflections 139,555 147,041 147,592 73,310 274,336
Unique reflections 29,897 21,456 21,509 19,210 35,886
Completeness (%)a 100 (100) 98.7 (97.2) 99.3 (97.9) 99.4 (99.6) 99.7 (99.9)
I/a 22.5 (2.7) 24.6 (2.6) 25.3 (3.0) 15.7 (2.1) 13.7 (2.7)
Rmerge (%)a,b 0.073 (0.50) 0.09 (0.76) 0.088 (0.68) 0.111 (0.79) 0.038 (0.28)
Figure of meritc before/after DM 0.39 for 20–2.9 Å/0.64 for 39–2.5 Å
Refinement
Resolution range (Å) 20–2.5 30–2.35
Reflections (free/test) 27,037/1,405 34,091/1,795
Rwork/Rfree (%)d 19.6/24.9 21.0/25.2
Protein 5,369 5,465
Water 243 155
r.m.s. bond length (Å) 0.0058 0.0067




a Values in parentheses are for reflections in the highest resolution bin.
b Rmerge  hiI(h,i)I(h)/hiI(h,i), where I(h,i) is the intensity of the ith measurement of h and I(h) is the corresponding average value for all imeasurements.
c Figure of merit  P()ei	/P(), where P() is the phase probability distribution and  is the phase.
d Rwork and Rfree  Fo Fc/Fo for the working set and test set (5%) of reflections.
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This considerable sequence divergence is reflected in significant struc-
tural changes in the FAK FERM domain as compared with other FERM
domain structures studied to date. As expected, the overall fold of the
FERMdomain is preserved, butmarked differences are observed both in
the structures of the individual lobes and in their relative orientations
within the domain as a whole (Fig. 2). In contrast, the FERMdomains of
merlin and ERM family members much more closely resemble one
another (they superimpose with overall root mean square deviations on
the order of 1 Å or less). We compare the FAK FERM domain with that
of radixin, a well studied ERM family member.
The 64-residue core of the F1 subdomain superimposes with that of
radixinwith an r.m.s. deviation of 1.4Å (Fig. 2A). The secondhelix in the
F1 subdomain (F1-2) is approximately two turns longer in FAK than in
ERM family members. Additionally, the 1-2 and 2-5 loop regions
are longer, and contain 310 helices not found in other FERM structures.
These insertions account for the 12 additional residues within the F1
domain of FAK as compared with the structurally aligned FERM
domain of radixin (Fig. 1C). Structural similarity with the F2 subdomain
of radixin is limited to helices 1 to 4; the 78 residues in this 4-helix
core superimpose with an r.m.s. deviation of 1.6 Å. The FAK F2 lobe
includes four structural elements that are not seen in other FERMstruc-
tures; these include three segments of 310 helix and a 9-residue helix2
,
all of which are inserted between core helices 2 and 3 (Figs. 1C and
2A). The F3 lobes of FAK and radixin superimpose with an r.m.s. devi-
ation of 1.5 Å over 73 residues for 6 of the 7 -strands and the 1 helix.
The relatively modest structural differences between the F3 subdo-
mains of FAK and radixin include a shift in the position of the 3-4
loop, a 310 helix within 4-5 turn in FAK, and a 7-residue insertion in
the loop connecting strands 5 and 6.
Perhaps the most striking structural difference between the FAK
FERM domain and other intact FERM structures determined to date is
the relative orientation of the subdomains. In particular, the position of
the F3 lobe with respect to the F1 and F2 lobes is markedly different in
FAK. The FAK FERM domain is shown superimposed with the struc-
turally related radixin andmerlin FERMdomains in Fig. 2B. The FAKF3
subdomain is rotated and translated such that its 1 helix is positioned
3.5–4 Å closer to the F1 lobe and its 5 strand is 9 Å closer to the F1
lobe than the equivalent regions in radixin andmerlin. This difference is
FIGURE 1. Structure and sequence comparison of the FAK FERM domain. A, schematic showing the domain organization of FAK. The FERM, tyrosine kinase, and focal adhesion
targeting (FAT) domains are indicated, as are principle tyrosine phosphorylation sites and the Src SH3 binding motif in the FERM/kinase linker segment. B, ribbon diagram of FAK FERM
domain containing amino acids 33–363. The three subdomains are labeled F1, F2, and F3 with -helices colored cyan, -strands colored green, and 310 helical turns in orange.
Secondary structure elements are labeled as shown in the sequence alignment below. C, structure-based sequence alignment of FERM domains with conserved residues highlighted
in yellow and identical residues in red. Avian FAK (cFAK), human FAK (hFAK), human Pyk2 (hPYK2), human Ezrin (hEz), human radixin (hRad), human moesin (hMoe), human merlin
(hMer), and human band 4.1R (h41R) are shown.
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much greater than the shift described in comparison of the active and
inactive-tail bound structures of moesin and ezrin (47, 57). The net
effect of this rearrangement is a significant difference in the interfaces of
F3 with both F1 and F2 as compared with other intact FERM structures.
The F3 lobe is less intimately associated with the F2 lobe in FAK (a
buried surface area of 749 Å2 as compared with 990 Å2 of contact in
radixin). In contrast, the F1–F3 interface is more intimate (compare
1207 Å2 buried in FAK with 1004 Å2 in radixin). Interacting residues
between the F1 and F3 domains of FAK include His99 with Glu338,
Arg127 with Asp342, and Asn339 with Val95 and Trp97. This novel posi-
tioning of F3 against F1 is the same in the two independent FAK mole-
cules in the crystallographic asymmetric unit and also observed in the
FAK405 structure, which has different crystal packing contacts.
The divergent structure of the FAK FERM domain also indicates a
divergence in function. The FERMdomains of ERMproteins bind phos-
phoinositide phosphatidylinositol 4,5-P2; this interaction is important
for localization of the ERM proteins in cells (24). The radixin FERM
domain has been crystallized in complex with inositol 1,4,5-trisphos-
phate (the soluble head group of phosphatidylinositol 4,5-P2) (22). The
IP3 head group binds radixin in a shallow, basic cleft between the F1 and
F3 domains (Fig. 3B). The FAKFERMdomain clearly cannot bind phos-
phoinositides in the analogous position (Fig. 3, A and C). In FAK, the
F1–F3 cleft is different in both structure and amino acid composition.
The interface between the F1 and F3 domains of FAK is narrow relative
to other FERM structures because of the divergent position of the F3
lobe as described above. Additionally, the presence of acidic residues
and the lack of basic residues within this cleft is expected to preclude
phosphoinositide coordination at this site in the FERM domain of FAK
(Fig. 3, C and D).
The FERM-Kinase Linker Segment—In human FAK, the FERM
domain ends at residue 352, and the kinase domain begins at approxi-
mately residue 415 (58). The intervening 60-residue linker segment is
important for regulation of FAK function, as it contains theTyr397 phos-
phorylation site (which when phosphorylated is bound by the Src SH2
domain) and also the binding site for the Src SH3 domain. The linker is
largely disordered in FAK399, however, in both the FAK399 and FAK405
structures the first 10 residues of the linker bind in the cleft between the
F1 and F3 lobes and in the putative peptide recognition groove on the F3
lobe (Fig. 4). In the longer FAK405 structure, the ordered region extends
to Lys375 and encompasses the Src SH3 docking site. Additionally, a
discontinuous segment of clear density is observed for residues 394–
FIGURE 3. Electrostatic surface representations of the FAK (A) and radixin (B) FERM
domains and detail of the F1–F3 cleft in FAK (C) and radixin (D). The electrostatic
surfaces are shaded blue in basic regions and red in acidic regions. In the radixin structure
(Protein Data Bank code 1GC6), inositol 1,4,5-trisphosphate (IP3) is bound in the center of
a basic cleft between the F1 and F3 lobes, where it is coordinated in part by the side
chains of three lysine residues (panel D). Note that this basic cleft is not present in the FAK
FERM domain (panels A and C), and that the proximal portion of the FERM-kinase linker
segment (the residues flanking Arg361) binds in this region (panel C).
FIGURE 2. Comparison of FAK with a represent-
ative ERM family FERM domain. A, the F1, F2, and
F3 subdomains of avian FAK (shown in cyan) and
human radixin (shown in yellow) were superim-
posed individually. The subdomains are highly
related but notable structural differences are
described in the text. B, superposition of the intact
FERM domains of FAK (cyan), radixin (yellow), and
merlin (red). The different orientation of FAK F3
with respect to the F1 and F2 lobes is apparent in
comparison with the overall structural conserva-
tion between radixin and merlin characteristics of
all ERM family and closely related FERM domains
studied to date.
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403 of the FERM-kinase linker; this segment encompasses the Tyr397
site (Fig. 5).
Just COOH-terminal to the 1 helix of F3, the polypeptide chain
turns back into the F1–F3 cleft, and makes numerous interactions with
both the F1 lobe and the F3 binding groove (Fig. 4, A and C). Contacts
with the F1 lobe include a salt-bridge hydrogen bond network involving
Arg361 in the linker and the side chains of Asp101 and His89 in the F1
lobe, and also a hydrogen bond between the carbonyl of Thr355 and the
side chain of Arg65 in the F1 lobe. The linker interaction with the F3
binding groove is stabilized by hydrophobic interactions of Phe358,
Ile359, and Ile360 and through a parallel -sheet interaction of residues
Phe358 to Ile360 with the 5 strand in the F3 binding groove (Fig. 4C). In
the FAK399 structure, the linker region beyondPro362 no longer contacts
the FERM domain. However, in one of the twomolecules in the FAK405
structure, the ordered region extends through the Src SH3 binding site
(residues 368–375), which interacts with the surface of the F3 lobe (Fig.
5, A and B). The RALPSIP sequence (the key residues of the RXXPXXP
Src SH3 binding motif are underlined) adopts a polyproline type II hel-
ical conformation and packs against the exposed -sheet of the F3 lobe.
Contacts with the F3 subdomain include 5 backbone-mediated hydro-
gen bond interactions including two with the side chains of Gln303 and
Gln317, and hydrophobic interactions involving Leu370 and Ile373 (Fig.
5B). Interestingly, polyproline motifs bind to EVH1 domains of Ena/
Vasp proteins, which also share the pleckstrin homology domain fold of
the F3 lobe, in a topologically similar location (59). The orientation and
specific interactions of the proline motif in the present structure, how-
ever, is not the same as that observed in EVH1 complexes.
The segment containing the phosphorylation site Tyr397 packs
against the F1 subdomain of both FERM molecules (Fig. 5, A and C).
This polypeptide consists of residues 394–403 and forms a 310 helix and
short -strand that extends the anti-parallel -sheet formed by the 1
and 2 strands of F1. This interface buries a total of 1047 Å2 and com-
prises 7 backbone-mediated hydrogen bondswith onlyThr62 of F1mak-
ing a specific side chain interaction and two side chain-mediated inter-
actions of Glu403 with Ser54 and His41 (Fig. 5C). There are no previously
identified examples of this surface of a FERMdomainmaking a protein-
protein interaction. The side chain of Tyr397 is surface exposed and in
close proximity to Lys70. The last ordered residue of the COOH-termi-
nal segment, Glu403, is near Lys38, His41, His75, and the cleft region
between the F1 and F2 subunits. Note that it is not possible to ascertain
whether the interaction of this segment is intramolecular or whether it
occurs between adjacent molecules in the crystal lattice because we do
not observe density for the preceding 20 residues. Either connectivity is
crystallographically plausible, but the fact that this construct is mono-
meric in solution suggests that the interaction is intramolecular.
DISCUSSION
The F3 binding groove, occupied by the NH2-terminal portion of the
linker segment in the present structure, is a well characterized interac-
tion site on FERM domains. In ERM family proteins, this groove is
occupied by part of the COOH-terminal actin-binding tail, which
makes intramolecular interactions with the FERM domain (43). Upon
activation, this autoinhibitory conformation is thought to be released,
allowing interaction with the cytoplasmic tails of cognate cell-surface
receptors (60). Indeed, the tail region of ICAM-2 was recently demon-
strated to bind at this site in a crystal structure of radixin complexed
with an ICAM-2 peptide (21). The peptide forms a -sheet interaction
with the 5 strand of the F3 lobe, thereby extending the -sheet (Fig.
FIGURE 4. Detailed view of the F3 lobe high-
lighting the linker interaction. A, ribbon dia-
gram of the FAK F3 lobe with the proximal portion
of the linker shown in stick form and colored
magenta. The details of this interaction are shown
schematically in panel C. B, the radixin F3 lobe (yel-
low) bound to a peptide representing the cyto-
plasmic tail of ICAM-2 (gray). C, schematic detail-
ing the interactions of the linker with the putative
ligand binding groove on the F3 lobe. Linker resi-
dues are indicated in magenta, FERM domain resi-
dues in cyan. Dashed lines indicate hydrogen bond
interactions and semicircles indicate hydrophobic
interactions. Note that the linker also contacts the
F1 lobe as indicated.
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4B). Additionally, the corresponding site in the talin FERM domain was
observed to bind an NPXY motif in the 3 integrin tail (48). Interest-
ingly, this binding site is also analogous to that bound by NPXY motif
sequences on the structurally homologous phosphotyrosine binding
domain, as seen, for example, in the insulin receptor substrate-1 phos-
photyrosine binding domain (61). Although the linker segment in FAK
binds to the F3 lobe in the same location, its mode of binding is quite
different from that in the structures noted above. The linker segment
binds in the opposite orientation, thus forming a parallel rather than
anti-parallel -sheet interaction with strand 5 (Fig. 4).
The significance of the interaction of theNH2-terminal portion of the
linker with the F3 lobe is unclear. It is possible that this portion of the
linker segment is simply an extension of the fold of the FAK FERM
domain itself, and therefore represents a structural divergence between
FAK and other FERMdomains. Alternatively, it is tempting to speculate
that it represents a regulatory interaction, masking all or part of the
binding site of an interacting protein. Like talin, FAKmay associate with
-integrin tails. If it is a regulatory interaction, the structure suggests
that it might be released by binding of a Src family protein to the SH3
and/or SH2 binding sites. Indeed, binding of a Src SH3 domain to the
RALPSIP sequence would preclude its interaction with the surface of
the F3 lobe andmight also destabilize the interaction of the linker in the
F3 groove by steric effects. The phosphorylation of Tyr397 is a key reg-
ulatory event in the activation of FAK and scaffolding properties that
recruit SH2-domain containing proteins such as Src family kinases,
phosphatidylinositol 3
-kinases, and Grb family adaptor proteins (62).
Phosphorylation and subsequent binding to the Tyr397 site will also
require its dissociation from the surface of the FERM domain.
Although structurally unrelated, the interactions of the linker seg-
ment with the FERM domain are reminiscent of the intramolecular
interactions between the SH3 domain and the SH2 kinase linker seg-
ment in Src family kinases. It is tempting to speculate that one or both of
the linker contacts may additionally participate in autoinhibitory inter-
actions with the kinase, in analogy with Src kinases where the SH3 and
linker together bind theN-lobe of the kinase (63). In FAK, association of
SH2-containing proteins may be an important step in the activation of
the kinase by facilitating disassembly of the FERM-linker and or FERM/
kinase intramolecular interactions. In loose analogy with Src kinases,
phosphorylation of Tyr397 and subsequent recruitment of a Src family
kinase to the linker segment might be expected to stabilize an open and
active conformation of FAK. The present structure will facilitate
mutagenesis studies designed to test these possibilities and to further
dissect the intramolecular interaction of the FERM domain with the
kinase domain.
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